| scholarly article | Q13442814 |
| P50 | author | Roland Hetzer | Q104513 |
| Sophie Van Linthout | Q56961031 | ||
| Carsten Tschöpe | Q90667359 | ||
| P2093 | author name string | Yeong-Hoon Choi | |
| Christof Stamm | |||
| Boris Nasseri | |||
| Tomo Saric | |||
| Stefan Hühn | |||
| P2860 | cites work | Reverse remodeling is associated with changes in extracellular matrix proteases and tissue inhibitors after mesenchymal stem cell (MSC) treatment of pressure overload hypertrophy. | Q53432725 |
| Improvement in hemodynamic performance, exercise capacity, inflammatory profile, and left ventricular reverse remodeling after intracoronary delivery of mesenchymal stem cells in an experimental model of pressure overload hypertrophy. | Q53500988 | ||
| Cyclin A2 induces cardiac regeneration after myocardial infarction and prevents heart failure. | Q53553910 | ||
| Mechanisms of action of mesenchymal stem cells in cardiac repair: potential influences on the cardiac stem cell niche. | Q53576712 | ||
| Bcl-2 Engineered MSCs Inhibited Apoptosis and Improved Heart Function | Q56979828 | ||
| Can Cold or Heat Shock Improve Skeletal Myoblast Engraftment in Infarcted Myocardium? | Q58108804 | ||
| Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts | Q59064540 | ||
| Mesoangioblasts, Vessel-Associated Multipotent Stem Cells, Repair the Infarcted Heart by Multiple Cellular Mechanisms | Q59120521 | ||
| Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction | Q22250889 | ||
| Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction | Q24534652 | ||
| Virus-free induction of pluripotency and subsequent excision of reprogramming factors | Q24644686 | ||
| Expression of p16(INK4a) in peripheral blood T-cells is a biomarker of human aging | Q24646862 | ||
| Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins | Q24653753 | ||
| Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium | Q24677311 | ||
| Multilineage potential of adult human mesenchymal stem cells | Q27860737 | ||
| Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors | Q27860937 | ||
| A perivascular origin for mesenchymal stem cells in multiple human organs | Q28131808 | ||
| Bone marrow cells regenerate infarcted myocardium | Q28210640 | ||
| Nuclear reprogramming and pluripotency | Q28249466 | ||
| Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart | Q28264555 | ||
| Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells | Q28269087 | ||
| Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages | Q28306800 | ||
| Low-energy shock wave for enhancing recruitment of endothelial progenitor cells: a new modality to increase efficacy of cell therapy in chronic hind limb ischemia | Q28582868 | ||
| Human induced pluripotent stem cells free of vector and transgene sequences | Q29547624 | ||
| Induced pluripotent stem cells generated without viral integration | Q29614343 | ||
| Generation of induced pluripotent stem cells using recombinant proteins | Q29619162 | ||
| piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells | Q29619409 | ||
| Adult cardiac stem cells are multipotent and support myocardial regeneration | Q29620122 | ||
| Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. | Q30444845 | ||
| Survival and maturation of human embryonic stem cell-derived cardiomyocytes in rat hearts | Q30492452 | ||
| Autologous bone marrow-derived stem cell therapy in combination with TMLR. A novel therapeutic option for endstage coronary heart disease: report on 2 cases | Q30781532 | ||
| Protocols for hematopoietic stem cell expansion from umbilical cord blood | Q37517964 | ||
| Proinflammatory cytokine effects on mesenchymal stem cell therapy for the ischemic heart. | Q37584728 | ||
| Therapeutic potential of adipose-derived stem cells in vascular growth and tissue repair | Q37641714 | ||
| Transplanted human bone marrow contributes to vascular endothelium | Q37695445 | ||
| Progenitor cells isolated from the human heart: a potential cell source for regenerative therapy. | Q39266763 | ||
| Circulating endothelial progenitor cells, vascular function, and cardiovascular risk | Q39513285 | ||
| Generation and characterization of functional cardiomyocytes using induced pluripotent stem cells derived from human fibroblasts | Q39803924 | ||
| Direct reprogramming of human neural stem cells by OCT4. | Q39806256 | ||
| Functional characterization of cardiomyocytes derived from murine induced pluripotent stem cells in vitro | Q39808804 | ||
| Generation of functional murine cardiac myocytes from induced pluripotent stem cells | Q39961528 | ||
| Shock waves activate in vitro cultured progenitors and precursors of cardiac cell lineages from the human heart | Q40167706 | ||
| Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair | Q40417766 | ||
| Stem cell differentiation requires a paracrine pathway in the heart | Q40698267 | ||
| Cellular cardiomyoplasty: myocardial regeneration with satellite cell implantation | Q41673982 | ||
| Embryonic stem cell therapy of heart failure in genetic cardiomyopathy | Q41853497 | ||
| Identification of myogenic-endothelial progenitor cells in the interstitial spaces of skeletal muscle | Q41904046 | ||
| Bone marrow-derived regenerated cardiomyocytes (CMG Cells) express functional adrenergic and muscarinic receptors | Q42516147 | ||
| Cryopreserved mesenchymal stromal cell treatment is safe and feasible for severe dilated ischemic cardiomyopathy | Q43251718 | ||
| Cardiac mesoangioblasts are committed, self-renewable progenitors, associated with small vessels of juvenile mouse ventricle. | Q44581360 | ||
| Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes | Q44710997 | ||
| Bone marrow mononuclear cell transplantation had beneficial effects on doxorubicin-induced cardiomyopathy | Q44829179 | ||
| Linear polyamine copper chelator tetraethylenepentamine augments long-term ex vivo expansion of cord blood-derived CD34+ cells and increases their engraftment potential in NOD/SCID mice | Q44926759 | ||
| Statins enhance migratory capacity by upregulation of the telomere repeat-binding factor TRF2 in endothelial progenitor cells. | Q45134152 | ||
| Targeted expression of cyclin D2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice | Q45171605 | ||
| Nestin-expressing neural stem cells identified in the scar following myocardial infarction | Q45191334 | ||
| Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium | Q45206400 | ||
| Stem cell mobilization by granulocyte colony-stimulating factor for myocardial recovery after acute myocardial infarction: a meta-analysis | Q45834434 | ||
| Cardiac myocytes derived from murine reprogrammed fibroblasts: intact hormonal regulation, cardiac ion channel expression and development of contractility. | Q45933444 | ||
| Transplantation of neonatal cardiomyocytes after permanent coronary artery occlusion increases regional blood flow of infarcted myocardium | Q46051542 | ||
| Dynamics of human myocardial progenitor cell populations in the neonatal period. | Q46724387 | ||
| Differentiation in vivo of cardiac committed human embryonic stem cells in postmyocardial infarcted rats. | Q47575065 | ||
| Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart | Q47611450 | ||
| Myocardial Assistance by Grafting a New Bioartificial Upgraded Myocardium (MAGNUM trial): clinical feasibility study | Q47898063 | ||
| Endothelial cells but not epithelial cells or cardiomyocytes are partially replaced by donor cells after allogeneic bone marrow and stem cell transplantation | Q48202531 | ||
| Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. | Q48414650 | ||
| Cellular repopulation of myocardial infarction in patients with sex-mismatched heart transplantation | Q48745556 | ||
| Age-related changes in the frequency of mesenchymal stem cells in the bone marrow of rats | Q48907638 | ||
| Advanced heart failure treated with continuous-flow left ventricular assist device | Q48952442 | ||
| Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. | Q51010411 | ||
| Survival, integration, and differentiation of cardiomyocyte grafts: a study in normal and injured rat hearts. | Q52175867 | ||
| Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans | Q31113632 | ||
| Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease | Q33200016 | ||
| Endomitosis and polyploidization of myocardial cells in the periphery of human acute myocardial infarction | Q33216860 | ||
| Restoration of cardiac progenitor cells after myocardial infarction by self-proliferation and selective homing of bone marrow-derived stem cells | Q33226565 | ||
| Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy | Q33257976 | ||
| Cardiac side population cells have a potential to migrate and differentiate into cardiomyocytes in vitro and in vivo | Q33270812 | ||
| Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis | Q33285990 | ||
| Bone marrow cells adopt the cardiomyogenic fate in vivo | Q33304156 | ||
| Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review | Q33340205 | ||
| Cardiomyocytes can be generated from marrow stromal cells in vitro | Q33843659 | ||
| Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure | Q33853869 | ||
| Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function | Q33863225 | ||
| Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function | Q33941111 | ||
| Evidence that human cardiac myocytes divide after myocardial infarction | Q33950386 | ||
| The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. | Q34010010 | ||
| Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial | Q34332467 | ||
| Pluripotency of spermatogonial stem cells from adult mouse testis | Q34505738 | ||
| Cardiomyocyte cell cycle regulation | Q34662444 | ||
| Producing primate embryonic stem cells by somatic cell nuclear transfer. | Q34713822 | ||
| Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors | Q34791180 | ||
| Immune properties of human umbilical cord Wharton's jelly-derived cells | Q34808849 | ||
| Generation of pluripotent stem cells from adult human testis. | Q34851175 | ||
| Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy | Q35918432 | ||
| Cardiopoietic programming of embryonic stem cells for tumor-free heart repair | Q36229704 | ||
| Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized study | Q36322384 | ||
| A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction | Q36634299 | ||
| Ex vivo expansion of umbilical cord blood stem cells for transplantation: growing knowledge from the hematopoietic niche | Q36681962 | ||
| Immunomodulation by mesenchymal stem cells and clinical experience | Q36975987 | ||
| Immunological barriers to embryonic stem cell-derived therapies. | Q37095718 | ||
| New ISSCR guidelines underscore major principles for responsible translational stem cell research | Q37337489 | ||
| Cell therapy for heart disease: great expectations, as yet unmet | Q37361102 | ||
| Cyclin D1 overexpression promotes cardiomyocyte DNA synthesis and multinucleation in transgenic mice | Q37368118 | ||
| Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. | Q37401842 | ||
| Ventricular assist device therapy | Q37474996 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 2-16 | |
| P577 | publication date | 2010-10-14 | |
| P1433 | published in | Cardiovascular Therapeutics | Q1871490 |
| P1476 | title | Cardiac cell therapies: the next generation | |
| P478 | volume | 29 |
| Q86965431 | Adult stem cells and cardiac regeneration |
| Q41538962 | Calcium-alginate hydrogel-encapsulated fibroblasts provide sustained release of vascular endothelial growth factor |
| Q36690614 | Endometrial regenerative cells for treatment of heart failure: a new stem cell enters the clinic |
| Q37989191 | From tendon to nerve: an MSC for all seasons |
| Q46510689 | Human Endomyocardial Biopsy Specimen-Derived Stromal Cells Modulate Angiotensin II-Induced Cardiac Remodeling. |
| Q36093158 | Human amniotic fluid stem cell preconditioning improves their regenerative potential |
| Q34103142 | Human cardiac-derived adherent proliferating cells reduce murine acute Coxsackievirus B3-induced myocarditis |
| Q36364300 | In search of new therapeutic targets and strategies for heart failure: recent advances in basic science |
| Q38603881 | Induced pluripotent stem cells in cardiovascular medicine |
| Q34245780 | Intra coronary freshly isolated bone marrow cells transplantation improve cardiac function in patients with ischemic heart disease |
| Q34223177 | Pharmacological and biological antiviral therapeutics for cardiac coxsackievirus infections. |
Search more.